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Equine West Nile Encephalitis
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In 1999 West Nile Virus (WNV) was first discovered in
the North Eastern United States. Clinical disease caused
by the virus was first identified in birds, followed by
humans and equines. By 2002 over 15,000 horses were
diagnosed in over 41 different states. Now WNV is
throughout the United States and is here to stay. Birds
are the primary reservoir for WNV in which the disease
is usually fatal.1 In the United States crows, blue jays,
and magpies have been the biggest reservoir
populations.3 West Nile Virus is transferred between
birds by mosquitos. When a bird is infected with WNV,
it serves as an amplifying host of the virus. This means
that the virus replicates quickly and results in large
amounts of virus in the bloodstream resulting in a
profound viremia. A viremic bird is then bitten by a
mosquito which then transfers WNV to horses, humans,
and other mammals. Infected mammals typically
experience a low viremia. As a result, mammals are
generally considered dead end hosts2 and mosquitos are
unable to transmit WNV from an infected mammal to an
uninfected mammal. Additionally, WNV infection can
be transmitted through blood transfusions.
Horses can exhibit clinical signs when they become
infected by WNV. As is common with many viral
infections, many horses will not experience any clinical
illness after becoming infected. However, WNV can
cross over the blood-brain barrier and cause disease in
the brain and spinal cord. This disease is referred to as
WNV encephalomyelitis and can vary in range and
severity. The most common signs of disease include
ataxia in the hindlimbs as well as twitching of the
muzzle and neck muscles. Other signs that may be seen
include fever, wandering, impaired vision and
generalized weakness. More severe signs can include
depression, stumbling, paralysis, recumbency and death.

Geriatric horses or any horse that becomes recumbent
(unable to get up) have a much higher risk of death as a
result of WNV infection.
West Nile Virus affects humans as well as other
mammals and birds. Local health organizations monitor
bird and mosquito populations to be able to predict when
human and horse cases will begin to show up. Weekly
updates for Utah can be found at
http://health.utah.gov/epi/diseases/WNV/surveillance/.
In horses, diagnosis of WNV disease is made by the
presence of clinical signs plus the detection of antibodies
in the bloodstream. In horses, the clinical signs of WNV
encephalomyelitis cannot be distinguished from other
equine neurologic diseases. Therefore, a blood test is
required to look for antibodies specific for WNV. Other
equine neurologic diseases, such as Equine Herpes Virus
(EHV), can also be fatal and can be spread from horse to
horse. This makes it important to distinguish WNV
infection from other neurologic diseases.
Treatment of WNV encephalomyelitis is mainly
supportive. There is no specific cure for infection from
WNV. Controlling pain and inflammation with antiinflammatories and fluid therapy is most often utilized.
Initiation of supportive care at an early onset of the
disease does lead to a more favorable outcome.3 The
mortality rate for infected horses is estimated to be 35%.
Approximately two-thirds of infected horses will
recover. However, 40% of those that survive will
continue to show clinical signs.2 Caution and safety must
be exercise around horses with lingering neurological
symptoms.

Prevention is the key to reducing your horse’s risk of
contracting WNV. Since 2003 equine WNV vaccines
have been available. Broodmares should receive this
vaccine 4-6 weeks prior to their due date to ensure
adequate antibody concentrations are in the colostrum
for the foal. If the dam was given her pre-foaling
vaccine, foals should start their vaccine series for WNV
at six months of age. It is important that you follow the
manufacturer’s label recommendation for dosing
frequency when starting the primary series. In heavily
affected areas, the vaccine can be administered as often
as every 4 months.1 It is vital that you visit with your
veterinarian when determining a vaccination schedule
for your horse.
In addition to vaccinating your horse, the American
Association of Equine Practitioners has given
recommendations to help eliminate mosquitos from
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horse areas.4 These steps include: eliminating standing
water (old tires, buckets, etc.), thoroughly cleaning water
troughs at least monthly, using larvicides to control
mosquito populations, keeping your horse inside during
the peak mosquito times of dusk to dawn, using insect
repellants on your horse specific for mosquitos, remove
birds from the stall area and protect yourself with proper
clothing and mosquito repellent.
In conclusion, it is critical that you work with your
veterinarian to determine the customized vaccination
schedule that your horse needs. You can also decrease
your horse’s exposure to WNV by taking steps to
decrease numbers of mosquitos. Finally, if you see any
clinical signs of WNV infection in your horse, call a
veterinarian immediately.

Fast Facts
Birds are the primary reservoir for WNV
WNV is mostly spread from an infected bird to an uninfected horse
WNV causes an encephalomyelitis in horses
Clinical signs can include fever, ataxia, twitching, weakness, stumbling, paralysis,
recumbency, coma and death
Diagnosis is made by observation of clinical signs and blood test
Treatment is mainly supportive care
Mortality rate is approximately 35%
Vaccination is vital for protection against WNV
Reducing mosquito numbers helps prevent WNV infection

References
1

American Association of Equine Practitioners: West
Nile Virus. Retrieved from
https://aaep.org/horsehealth/west-nile-virus

3

Merck Veterinary Manual: Overview of Equine
Arboviral Encephalomyelitis. Retrieved from
https://www.merckvetmanual.com/nervoussystem/equine-arboviral-encephalomyelitis/overview-ofequine-arboviral-encephalomyelitis

2

Kansas State University: West Nile Virus Fact Sheet
June 2014. Retrieved from https://www.vet.kstate.edu/vhc/services/equine/timely-topics/wnv-factsheet.pdf

4

American Association of Equine Practitioners: West
Nile Virus. Retrieved from
https://aaep.org/horsehealth/10-tips-reducing-yourhorses-west-nile-risk

Utah State University is committed to providing an environment free from harassment and other forms of illegal discrimination based
on race, color, religion, sex, national origin, age (40 and older), disability, and veteran’s status. USU’s policy also prohibits
discrimination on the basis of sexual orientation in employment and academic related practices and decisions. Utah State University
employees and students cannot, because of race, color, religion, sex, national origin, age, disability, or veteran’s status, refuse to hire;
discharge; promote; demote; terminate; discriminate in compensation; or discriminate regarding terms, privileges, or conditions of
employment, against any person otherwise qualified. Employees and students also cannot discriminate in the classroom, residence
halls, or in on/off campus, USU-sponsored events and activities. This publication is issued in furtherance of Cooperative Extension
work, acts of May 8 and June 30, 1914, in cooperation with the U.S. Department of Agriculture, Kenneth L. White, Vice President for
Extension and Agriculture, Utah State University.

